The present invention relates to the field of metabolic research. KRIB
polypeptides have been identified that are beneficial in the treatment of
metabolic disorders. These compounds should be effective for reducing
body mass and for treating metabolic disorders. These metabolic disorders
include hyperlipidemia, atherosclerosis, diabetes, and hypertension.